Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Ramzi Dagher"'
Publikováno v:
Platform Trial Designs in Drug Development ISBN: 9781315167756
Platform Trial Designs in Drug Development
Platform Trial Designs in Drug Development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c6198ec782b7f4a2cc730a1a8f6616d
https://doi.org/10.1201/9781315167756-7
https://doi.org/10.1201/9781315167756-7
Autor:
Frank M. Balis, Alberta A. Aikin, Crystal L. Mackall, Nalini Jayaprakash, Brigitte C. Widemann, Ramzi Dagher, Douglas S. Hawkins, Donna Bernstein, Elizabeth Fox, Lee J. Helman, Lauren Long, Seth M. Steinberg
Publikováno v:
Clinical Cancer Research. 15:7361-7367
Purpose: To compare the effectiveness, tolerance, and pharmacokinetics of a single dose of pegfilgrastim to daily filgrastim in children and young adults with sarcomas treated with dose-intensive combination chemotherapy. Experimental Design: Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa1dd49b41cee550ac017946be4e4639
https://doi.org/10.1158/1078-0432.ccr-09-0761
https://doi.org/10.1158/1078-0432.ccr-09-0761
Publikováno v:
The Oncologist. 13:445-450
Learning Objectives After completing this course, the reader will be able to: Evaluate anthracycline tissue injury resulting from drug extravasation.Administer dexrazoxane in its new role of reducing extravasation tissue injury.Describe the proposed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::089946d8b1a3daef8f7fe6db0adf324b
https://doi.org/10.1634/theoncologist.2007-0247
https://doi.org/10.1634/theoncologist.2007-0247
Publikováno v:
Pediatric Clinics of North America. 55:187-209
This article discusses the principles that guide good clinical practice standards, with particular emphasis on how they to relate to pediatric oncology research and recent efforts at harmonization. The authors review the clinical trials process and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f1601d166710baca1f88bdea143cf4
https://doi.org/10.1016/j.pcl.2007.10.008
https://doi.org/10.1016/j.pcl.2007.10.008
Autor:
Rajeshwari Sridhara, Ann T. Farrell, Richard Pazdur, Chia-Wen Ko, Ramzi Dagher, Robert C. Kane, Robert Justice
Publikováno v:
Clinical Cancer Research. 13:5291-5294
Purpose: To describe the Food and Drug Administration review and marketing approval considerations for bortezomib (Velcade) for the treatment of patients with mantle cell lymphoma. Experimental Design: Food and Drug Administration reviewed a multicen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad4dbf257590d6e868e19872a66abff0
https://doi.org/10.1158/1078-0432.ccr-07-0871
https://doi.org/10.1158/1078-0432.ccr-07-0871
Autor:
Jogarao V. S. Gobburu, Edwin P. Rock, Cheng Yi Liang, Sophia Abraham, Nallaperumal Chidambaram, S. Leigh Verbois, David E. Morse, Janet X. Jiang, Shenghui Tang, Richard Pazdur, Robert Justice, Roshni Ramchandani, Vicki L. Goodman, Ramzi Dagher, Brian Booth, Kooros Mahjoob
Publikováno v:
Clinical Cancer Research. 13:1367-1373
Purpose: To describe the Food and Drug Administration (FDA) review and approval of sunitinib malate (Sutent). Sunitinib received regular approval for the treatment of gastrointestinal stromal tumor (GIST) after disease progression or intolerance to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3182d3fb195191d614a250fba0132840
https://doi.org/10.1158/1078-0432.ccr-06-2328
https://doi.org/10.1158/1078-0432.ccr-06-2328
Publikováno v:
Clinical Cancer Research. 10:8147-8151
Purpose: Docetaxel, a taxane previously approved for the treatment of breast cancer and non–small cell lung cancer, was approved by the United States Food and Drug Administration on May 19, 2004 for use in combination with prednisone for the treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed3c393fc725176fe0f3a0ed9f701962
https://doi.org/10.1158/1078-0432.ccr-04-1402
https://doi.org/10.1158/1078-0432.ccr-04-1402
Autor:
Gerald H. Sokol, Alison Martin, Martin H. Cohen, Amna Ibrahim, Richard Pazdur, Nancy S. Scher, Ramzi Dagher, Grant A. Williams, Donna Griebel
Publikováno v:
The Oncologist. 7:393-400
The purpose of this report is to summarize information on drugs recently approved by the U.S. Food and Drug Administration. Three drugs have recently been approved: Gleevec™ (imatinib mesylate) at a starting dose of 400 or 600 mg daily for the trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36128623d76541fb89740bf4d3fe089
https://doi.org/10.1634/theoncologist.7-5-393
https://doi.org/10.1634/theoncologist.7-5-393
Autor:
Lauren Long, Lynn Sorbara, Maria Tsokos, Lee J. Helman, Donna Bernstein, Mark Raffeld, Crystal L. Mackall, Shimareet Kumar, Ramzi Dagher, Thu Anh Pham
Publikováno v:
Journal of Pediatric Hematology/Oncology. 23:221-224
To analyze retrospectively results of reverse transcription polymerase chain reaction (RT-PCR) testing and demographic information in patients with known or suspected Ewing sarcoma/primitive neuroectodermal tumor family of tumors referred to the Nati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af438b7821909237484f6e6f06ec8902
https://doi.org/10.1097/00043426-200105000-00009
https://doi.org/10.1097/00043426-200105000-00009
Publikováno v:
The Oncologist. 5:441-444
The majority of children with cancer receive therapy as participants in clinical research protocols coordinated by national pediatric cooperative groups. One of the highest priorities of these groups is the development of novel therapies. Due to diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f09772528fb040725bfb83fd7cba2d
https://doi.org/10.1634/theoncologist.5-6-441
https://doi.org/10.1634/theoncologist.5-6-441